page contents
Connect with us

Health & Lifestyle

Research reveals how Electrode stimulation helps women orgasm

Published

on

Healyth
Female sexual dysfunction, often characterized by an inability to orgasm, affects a large number of women. However, scientists may now have stumbled upon an effective and noninvasive treatment for this condition: neuromodulation.
Around 40 percent of women experience sexual dysfunction, which is defined as “a problem that occurs during the sexual response cycle that prevents the individual from experiencing satisfaction from sexual activity.”

Currently, there are few treatments for female sexual dysfunction, and these have generally been ineffective.

Recently, however, researchers from the University of Michigan in Ann Arbor have stumbled upon a therapy that, surprisingly, seems to boost women’s sexual function.



The scientists noticed that applying neuromodulation treatments, which involves light and targeted electrical stimulation, for bladder dysfunction seemed to also improve some of the women’s sexual function.

 “In this particular treatment, a patient receives nerve stimulation therapy once a week to improve neural signaling and function in the muscles that control the bladder,” explains researcher Tim Bruns.

“The nerves controlling the pelvic organs start out in the same location in the spinal cord and branch out,” he adds.

Bruns and colleagues found that stimulating one particular spot — an area close to the tibial nerve found in the ankle — helps treat bladder dysfunction.

FOLLOW US ON:
 INSTAGRAMLINKEDINYOUTUBETWITTER & FACEBOOK

It is unclear why placing electrodes on the ankle helps stimulate the pelvic area, but the team believes that the nerves that spread to the food may interact, in the region of the spinal cord, with nerves that reach the pelvic area.

This, the scientists say, may mean that synaptic routes overlap, and the electrical stimulation therefore comes to benefit the pelvic organs.

Because there was little to no research into whether this kind of therapy could help improve sexual function in women, Bruns and his colleagues decided to conduct the current studies both in animals and in humans.

The investigators tested the therapy’s effectiveness in a rat model. In the rodents, they stimulated nerves in both the genital and ankle regions. After about 15–30 minutes, they saw that the rats experienced a significant increase in vaginal blood flow, suggesting increased sensitivity.



In the recent study, Bruns and team then worked with female volunteers with healthy bladders but who were trying to overcome sexual dysfunction.

The volunteers all received 12 transcutaneous electrical nerve stimulation therapy sessions, which lasted for half an hour each. During the sessions, the researchers placed electrodes either around the women’s genital areas or on their ankles.

After these sessions, 8 out of the 9 participants reported more intense arousal, better vaginal lubrication, or being able to achieve orgasm again.

The scientists have published these findings in the journal Neuromodulation and note that their results exceed expectations.

 “Across a variety of clinical studies, if you get a 50 percent improvement in symptoms, you can consider that a successful response,” notes Bruns, adding, “We had four participants meet or exceed that threshold.”
TO DOWNLOAD OUR MOBILE NEWS APP CLICK HERE
WATCH RUSSIA 2018 HIGHLIGHTS HERE
-MedicalNewsToday

Health & Lifestyle

DR Congo blame Unending Ebola Outbreak on Violence , Community Mistrust.

Published

on

DR Congo Ministry of Health spokesperson Jessica Ilunga has declared that violence and community mistrust have continued to hamper all efforts to control and end the fresh Ebola outbreak, which started Aug. 1.



Though according to the World Health Organization the number of new Ebola cases has dropped slightly in the Democratic Republic of the Congo as there are 33% fewer cases to date in February compared with the same time period in December per STAT’s Helen Branswell, but some experts warn Axios that there remain signs that this outbreak is far from over.

Meanwhile, some experts warn that, that doesn’t mean the world’s second-largest Ebola outbreak on record is yet under control, and in fact it could simply be moving to new areas of the sprawling country.

 IMG-20180912-WA0030

Johns Hopkins’ public health expert Jennifer Nuzzo maintains there are several reasons people should continue to view this outbreak as a cause for concern.

However, Nuzzo said Congo needs more than money from the international community and the U.S. in particular. Safety concerns have largely caused the CDC to limit its Ebola experts to the capital city of Kinshasa, where some have returned after being evacuated during an uptick in election-related violence, Nuzzo added that Now is the time for the U.S. to send them into the field.

TO DOWNLOAD OUR MOBILE NEWS APP CLICK HERE

Continue Reading

Health & Lifestyle

Sports head injuries Balanced reportage is required – Experts

Published

on

A group of more than 60 leading international neuroscientists, including Mark Herceg, PhD, a neuropsychologist at Northwell Health’s Phelps Hospital in Sleepy Hollow, NY, and a member of The Feinstein Institute for Medical Research, published a correspondence today in The Lancet Neurology, asking for balance when reporting on sports-related injury chronic traumatic encephalopathy (CTE). CTE is a type of dementia associated with exposure to repeated concussions, and has been linked with a variety of contact sports such as boxing, football, American football and rugby.



Although CTE is commonly featured in the news media and discussed among peers, the medical community is just beginning to understand how to recognize the disease, guidelines for how to assess its severity have yet to be established.

“We don’t currently have a clear understanding of the link between CTE pathology and any specific symptoms,” noted Dr. Herceg. “It’s important to note to the public at large that CTE is at an early stage of scientific and medical understanding, with many important aspects of the disease yet to be established.”

 IMG-20180912-WA0030

“Dr. Herceg and his colleague’s CTE research is timely and impactful as a major step forward to more clearly defining the risk and prevalence of this important syndrome,” said Kevin J. Tracey, MD, president and CEO of the Feinstein Institute.

TO DOWNLOAD OUR MOBILE NEWS APP CLICK HERE

-Northwell Health

Continue Reading

Facebook

Advertisement
Advertisement

Trending

Copyright © 2018 Anttention Media. All rights reserved